FIG
CELG

Fortress Investment Group’s Celgene Corp CELG Stock Holding History

Fortress Investment Group’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-74,200
Closed -$6.27M – 211
2013
Q4 		$6.27M Buy
+74,200
New +$5.87M 0.1% 39

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fortress Investment Group's CELG Position: Q1 2014 in Review

Fortress Investment Group sold out of Celgene Corp (CELG) in Q1 2014, closing a stake of 74,200 shares — an estimated $6.27M sold.

Fortress Investment Group first reported a position in CELG in Q4 2013 and held it in 1 quarter. The position peaked at $6.27M in Q4 2013. 980 funds tracked by Wall St. Rank hold CELG as of Q1 2014.

  • Fortress Investment Group reported no remaining Celgene Corp position as of Q1 2014 after selling out during the quarter.
  • Fortress Investment Group sold 74,200 Celgene Corp shares in Q1 2014, an estimated $6.27M.
  • Fortress Investment Group first reported a position in Celgene Corp in Q4 2013 and held it in 1 quarter.
  • Fortress Investment Group's Celgene Corp position peaked at $6.27M in Q4 2013.
  • 980 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2014.

Based on Fortress Investment Group's 13F filing for Q1 2014, filed 15 May 2014.